275 related articles for article (PubMed ID: 32453941)
1. N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.
Kosciuk T; Lin H
ACS Chem Biol; 2020 Jul; 15(7):1747-1758. PubMed ID: 32453941
[TBL] [Abstract][Full Text] [Related]
2. The structure of myristoyl-CoA:protein N-myristoyltransferase.
Bhatnagar RS; Fütterer K; Waksman G; Gordon JI
Biochim Biophys Acta; 1999 Nov; 1441(2-3):162-72. PubMed ID: 10570244
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication.
Devadas B; Lu T; Katoh A; Kishore NS; Wade AC; Mehta PP; Rudnick DA; Bryant ML; Adams SP; Li Q
J Biol Chem; 1992 Apr; 267(11):7224-39. PubMed ID: 1559967
[TBL] [Abstract][Full Text] [Related]
4. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
[TBL] [Abstract][Full Text] [Related]
5. N-myristoylation: from cell biology to translational medicine.
Yuan M; Song ZH; Ying MD; Zhu H; He QJ; Yang B; Cao J
Acta Pharmacol Sin; 2020 Aug; 41(8):1005-1015. PubMed ID: 32203082
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
Das U; Kumar S; Dimmock JR; Sharma RK
Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
[TBL] [Abstract][Full Text] [Related]
7. In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.
Chauhan R; Datzkiw D; Varma Shrivastav S; Shrivastav A
PLoS One; 2018; 13(3):e0194612. PubMed ID: 29579063
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the discovery of N-myristoyltransferase inhibitors.
Zhao C; Ma S
ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
[TBL] [Abstract][Full Text] [Related]
9. Structural and Large-scale Analysis Unveil the Intertwined Paths Promoting NMT-catalyzed Lysine and Glycine Myristoylation.
Rivière F; Dian C; Dutheil RF; Monassa P; Giglione C; Meinnel T
J Mol Biol; 2022 Nov; 434(22):167843. PubMed ID: 36181773
[TBL] [Abstract][Full Text] [Related]
10. High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation.
Dian C; Pérez-Dorado I; Rivière F; Asensio T; Legrand P; Ritzefeld M; Shen M; Cota E; Meinnel T; Tate EW; Giglione C
Nat Commun; 2020 Feb; 11(1):1132. PubMed ID: 32111831
[TBL] [Abstract][Full Text] [Related]
11. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
[TBL] [Abstract][Full Text] [Related]
12. Structure of N-myristoyltransferase from Aspergillus fumigatus.
Shimada T; Suzuki M; Katakura S
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
[TBL] [Abstract][Full Text] [Related]
13. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
[TBL] [Abstract][Full Text] [Related]
14. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):541-57. PubMed ID: 11955008
[TBL] [Abstract][Full Text] [Related]
15. N-myristoyltransferase.
Rajala RV; Datla RS; Moyana TN; Kakkar R; Carlsen SA; Sharma RK
Mol Cell Biochem; 2000 Jan; 204(1-2):135-55. PubMed ID: 10718634
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
17. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
18. Use of alkyne-tagged myristic acid to detect N-terminal myristoylation.
Xu Y; Lin H
Methods Enzymol; 2023; 684():191-208. PubMed ID: 37230589
[TBL] [Abstract][Full Text] [Related]
19. Post-translational myristoylation: Fat matters in cellular life and death.
Martin DD; Beauchamp E; Berthiaume LG
Biochimie; 2011 Jan; 93(1):18-31. PubMed ID: 21056615
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.
Raju RV; Sharma RK
Mol Cell Biochem; 1996 May; 158(2):107-13. PubMed ID: 8817471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
